SI1940439T1 - Zmanjĺ anje nastanka postoperativne adhezije z intraperotonealnim glutaminom - Google Patents

Zmanjĺ anje nastanka postoperativne adhezije z intraperotonealnim glutaminom

Info

Publication number: SI1940439T1
Authority: SI; Slovenia
Prior art keywords: glutamine; patient; adhesion formation; peritoneum; reducing post
Prior art date: 2005-08-11

Application number

SI200630887T

Other languages

English (en)

Inventor

Adebola O E Obayan

Original Assignee

Univ Saskatchewan

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2005-08-11

Filing date

2006-08-11

Publication date

2011-02-28

2006-08-11 Application filed by Univ Saskatchewan filed Critical Univ Saskatchewan

2011-02-28 Publication of SI1940439T1 publication Critical patent/SI1940439T1/sl

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L31/16—Biologically active materials, e.g. therapeutic substances
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/05—Dipeptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/04—Macromolecular materials
- A61L31/043—Proteins; Polypeptides; Degradation products thereof
- A61L31/047—Other specific proteins or polypeptides not covered by A61L31/044 - A61L31/046
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/08—Materials for coatings
- A61L31/10—Macromolecular materials
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L31/145—Hydrogels or hydrocolloids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L31/148—Materials at least partially resorbable by the body
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
- A61L2300/21—Acids
- A61L2300/214—Amino acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
- A61L2300/25—Peptides having up to 20 amino acids in a defined sequence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
- A61L2300/252—Polypeptides, proteins, e.g. glycoproteins, lipoproteins, cytokines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/412—Tissue-regenerating or healing or proliferative agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/424—Anti-adhesion agents

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Epidemiology (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Surgery (AREA)
Engineering & Computer Science (AREA)
Vascular Medicine (AREA)
Heart & Thoracic Surgery (AREA)
Dispersion Chemistry (AREA)
Dermatology (AREA)
Biomedical Technology (AREA)
Bioinformatics & Cheminformatics (AREA)
Molecular Biology (AREA)
Gastroenterology & Hepatology (AREA)
Immunology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Neurosurgery (AREA)
Organic Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicinal Preparation (AREA)
Materials For Medical Uses (AREA)

SI200630887T 2005-08-11 2006-08-11 Zmanjĺ anje nastanka postoperativne adhezije z intraperotonealnim glutaminom SI1940439T1 (sl)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US70717305P	2005-08-11	2005-08-11
EP20060775098 EP1940439B1 (en)	2005-08-11	2006-08-11	Reducing post-operative adhesion formation with intraperitoneal glutamine
PCT/CA2006/001319 WO2007016791A1 (en)	2005-08-11	2006-08-11	Reducing post-operative adhesion formation with intraperitoneal glutamine

Publications (1)

Publication Number	Publication Date
SI1940439T1 true SI1940439T1 (sl)	2011-02-28

Family

ID=37727066

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
SI200630887T SI1940439T1 (sl)	2005-08-11	2006-08-11	Zmanjĺ anje nastanka postoperativne adhezije z intraperotonealnim glutaminom

Country Status (15)

Country	Link
US (5)	US20100260819A1 (sl)
EP (1)	EP1940439B1 (sl)
JP (1)	JP5194207B2 (sl)
AT (1)	ATE485829T1 (sl)
AU (1)	AU2006279218B2 (sl)
CA (1)	CA2618600C (sl)
CY (1)	CY1112051T1 (sl)
DE (1)	DE602006017864D1 (sl)
DK (1)	DK1940439T3 (sl)
ES (1)	ES2355159T3 (sl)
HK (1)	HK1120223A1 (sl)
PL (1)	PL1940439T3 (sl)
PT (1)	PT1940439E (sl)
SI (1)	SI1940439T1 (sl)
WO (1)	WO2007016791A1 (sl)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SI1940439T1 (sl)	2005-08-11	2011-02-28	Univ Saskatchewan	Zmanjĺ anje nastanka postoperativne adhezije z intraperotonealnim glutaminom
CA2578647A1 (en) *	2007-02-15	2008-08-15	University Of Saskatchewan	Reducing post-operative adhesion formation with intraperitoneal glutamine
PL2129370T3 (pl)	2007-03-02	2013-04-30	Zytoprotec Gmbh	Płyn do dializy otrzewnowej na bazie węglowodanów, zawierający resztę glutaminy
US20100082113A1 (en) *	2008-04-29	2010-04-01	Peter Gingras	Tissue repair implant
AU2011274224A1 (en) *	2010-06-28	2013-01-17	AdeTherapeutics, Inc	Keloid treatment
CN104379184A (zh)	2012-08-16	2015-02-25	尼普洛株式会社	防粘连材料
JP7160683B2 (ja) *	2016-04-29	2022-10-25	ザボードオブトラスティーズオブザレランドスタンフォードジュニアユニバーシティー	術後癒着の予防及び治療のための方法及び組成物
CN109789249B (zh)	2016-06-15	2022-01-25	土耳其科学技术研究理事会	多功能疝气贴片
US10500318B1 (en) *	2018-07-03	2019-12-10	Temple Therapeutics BV	Dosing regimens for treating hypoxia-associated tissue damage
AU2022271004A1 (en) *	2021-05-07	2023-11-16	Temple Therapeutics BV	Methods of treating fibrosis and hypoxia-associated damage to peripheral nerves

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1990009396A1 (fr) *	1989-02-08	1990-08-23	Kuraray Co., Ltd.	Peptide et adsorbant le comprenant immobilise sur un support
US5248697A (en)	1990-09-20	1993-09-28	Brigham And Women's Hospital	Enhancement of glutathione levels with glutamine
CA2114290C (en) *	1993-01-27	2006-01-10	Nagabushanam Totakura	Post-surgical anti-adhesion device
US5425740A (en) *	1994-05-17	1995-06-20	Hutchinson, Jr.; William B.	Endoscopic hernia repair clip and method
US6965014B1 (en) *	1996-01-16	2005-11-15	Baxter International Inc.	Fibrin material and method for producing and using the same
US6280745B1 (en) *	1997-12-23	2001-08-28	Alliance Pharmaceutical Corp.	Methods and compositions for the delivery of pharmaceutical agents and/or the prevention of adhesions
US5693671A (en) *	1996-05-01	1997-12-02	Harbor-Ucla Research And Education Institute	L-glutamine therapy for sickle cell diseases and thalassemia
GB9609993D0 (en)	1996-05-14	1996-07-17	Norbrook Lab Ltd	Oral rehydration product
US6797729B1 (en) *	1996-06-28	2004-09-28	Baxter International Inc.	Therapeutic glutamine and N-actyl-cysteine composition
US6063061A (en) *	1996-08-27	2000-05-16	Fusion Medical Technologies, Inc.	Fragmented polymeric compositions and methods for their use
US6495579B1 (en) *	1996-12-02	2002-12-17	Angiotech Pharmaceuticals, Inc.	Method for treating multiple sclerosis
AU8918898A (en) *	1997-08-25	1999-03-16	Harold Brem	Prevention of adhesions and excessive scar formation using angiogenesis inhibi tors
WO1999065948A1 (en) *	1998-06-16	1999-12-23	Biogen, Inc.	Variant type ii tgf-beta receptor fusion proteins and methods
EP1100464A1 (en)	1998-07-31	2001-05-23	Korea Institute Of Science And Technology	Lipid emulsion and solid lipid nanoparticle as a gene or drug carrier
US6613070B2 (en) *	1998-08-04	2003-09-02	Baxter International Inc.	System and method for sealing vascular penetrations with hemostatic gels
US20030007951A1 (en)	2000-08-23	2003-01-09	Richard Franklin	Treatment of trauma
EP1555896A1 (en)	2002-10-08	2005-07-27	Abbott Laboratories	Methods and compositions for providing glutamine
WO2005030242A1 (en)	2003-09-26	2005-04-07	University Of Florida Research Foundation, Inc	Arginyl-glutamine dipeptide for treatment of pathological vascular proliferation
SI1940439T1 (sl)	2005-08-11	2011-02-28	Univ Saskatchewan	Zmanjĺ anje nastanka postoperativne adhezije z intraperotonealnim glutaminom

2006
- 2006-08-11 SI SI200630887T patent/SI1940439T1/sl unknown
- 2006-08-11 AU AU2006279218A patent/AU2006279218B2/en active Active
- 2006-08-11 JP JP2008525352A patent/JP5194207B2/ja active Active
- 2006-08-11 ES ES06775098T patent/ES2355159T3/es active Active
- 2006-08-11 WO PCT/CA2006/001319 patent/WO2007016791A1/en active Application Filing
- 2006-08-11 DE DE200660017864 patent/DE602006017864D1/de active Active
- 2006-08-11 DK DK06775098T patent/DK1940439T3/da active
- 2006-08-11 PT PT06775098T patent/PT1940439E/pt unknown
- 2006-08-11 AT AT06775098T patent/ATE485829T1/de active
- 2006-08-11 CA CA2618600A patent/CA2618600C/en active Active
- 2006-08-11 PL PL06775098T patent/PL1940439T3/pl unknown
- 2006-08-11 US US12/063,423 patent/US20100260819A1/en not_active Abandoned
- 2006-08-11 EP EP20060775098 patent/EP1940439B1/en active Active
2009
- 2009-01-08 HK HK09100189A patent/HK1120223A1/xx unknown
2011
- 2011-01-04 CY CY20111100013T patent/CY1112051T1/el unknown
2013
- 2013-02-27 US US13/779,362 patent/US9011883B2/en active Active
2015
- 2015-03-17 US US14/660,382 patent/US20150250928A1/en not_active Abandoned
2017
- 2017-04-05 US US15/480,148 patent/US20170203013A1/en not_active Abandoned
2018
- 2018-11-05 US US16/180,637 patent/US10799622B2/en active Active

Also Published As

Publication number	Publication date
US20150250928A1 (en)	2015-09-10
CA2618600C (en)	2017-05-02
US10799622B2 (en)	2020-10-13
ES2355159T3 (es)	2011-03-23
EP1940439A4 (en)	2009-07-08
WO2007016791A8 (en)	2008-09-18
WO2007016791A1 (en)	2007-02-15
AU2006279218B2 (en)	2013-05-02
JP2009504576A (ja)	2009-02-05
EP1940439B1 (en)	2010-10-27
US20170203013A1 (en)	2017-07-20
US9011883B2 (en)	2015-04-21
DE602006017864D1 (de)	2010-12-09
US20130171209A1 (en)	2013-07-04
PT1940439E (pt)	2010-12-17
ATE485829T1 (de)	2010-11-15
PL1940439T3 (pl)	2011-04-29
EP1940439A1 (en)	2008-07-09
JP5194207B2 (ja)	2013-05-08
HK1120223A1 (en)	2009-03-27
US20100260819A1 (en)	2010-10-14
CY1112051T1 (el)	2015-11-04
CA2618600A1 (en)	2007-02-15
US20190111189A1 (en)	2019-04-18
DK1940439T3 (da)	2011-02-14
AU2006279218A1 (en)	2007-02-15

Publication	Publication Date	Title
HK1120223A1 (en)	2009-03-27	Reducing post-operative adhesion formation with intraperitoneal glutamine
MX342613B (es)	2016-10-06	Geles con base de acido hialuronico que incluyen agentes anestesicos.
MY146111A (en)	2012-06-29	Acylaminopyrazoles as fgfr inhibitors
ATE468113T1 (de)	2010-06-15	Therapeutisches mittel für ein weichteilsarkom
DE602007014186D1 (de)	2011-06-09	Triazin-11-beta-hydroxysteroid-dehydrogenase-artige hemmer
WO2008073670A3 (en)	2008-11-27	Unit dose formulations and methods of treating thrombosis with an oral factor xa inhibitor
DE60327089D1 (de)	2009-05-20	Systeme zum verschieben und/oder zurückhalten von gewebe in den oberen atemwegen
ES2356883A1 (es)	2011-04-14	Composicion para el tratamiento del dolor y/o la inflamacion.
MX2010007295A (es)	2010-10-11	Composiciones acuosas estables de ciclosporina.
TW200509949A (en)	2005-03-16	Pharmaceutical compositions and methods relating to inhibiting fibrous adhesions using various agents
PL1888013T3 (pl)	2009-09-30	Biologicznie przyswajalne wypełniacze składające się z liposomów fosfolipidowych i kwasu hialuronowego i/lub jego pochodnych
MX2008011633A (es)	2008-12-16	Aminoquinolonas como inhibidores de gsk-3.
SG159505A1 (en)	2010-03-30	Prevention and treatment of thromboembolic disorders
MX2009006695A (es)	2009-09-14	P-mentan-3-carboxamida sustituida con nitrogeno y sus usos.
WO2008009210A8 (fr)	2009-01-08	Composés de dihydropyrimidine optiquement purs et leurs utilisations dans la fabrication d'un médicament pour traiter ou prévenir des viroses
WO2007133796A3 (en)	2008-02-07	Methods and compositions for treatment of sleep apnea comprising administration of an endothelin antagonist
WO2010054068A3 (en)	2010-08-19	Cyclic adenosine monophosphates for reducing the formation of adhesions
MX2007005509A (es)	2007-07-09	Composicion y viscoelastica de polimero natural triple.
ATE501719T1 (de)	2011-04-15	Methoden und zusammensetzungen zur beruhigung von mund- und nasenschleimhäuten
WO2019139956A3 (en)	2020-04-16	Prevention and treatment of organ fibrosis
NZ533483A (en)	2006-03-31	Combinations of viscoelastics for use during surgery
GEP20063822B (en)	2006-05-10	Diclofenac-based composition for the topical treatment of oropharyngeal cavity disorders
WO2007047893A3 (en)	2007-06-21	Use of dasatinib for the treatment of bone metastasis
RS51420B (en)	2011-02-28	HYPERSTRUCTURE AMYLOPECTIN FOR USE IN THE PROCEDURES OF SURGICAL OR THERAPEUTIC TREATMENT OF mammals OR IN THE PROCEDURES OF DIAGNOSIS, AND PARTICULARLY FOR USE AS A PLASMA VOLUME EXPANDER
EP1789068A4 (en)	2007-10-17	COMPOSITION AND METHOD FOR PREVENTING OR TREATING STOMATITIS